Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« When Are You Most Alert? | Main | Neurotech Leaders to Gather in SF Oct. 21-22 »

September 20, 2005

Brainy Scientists at UPenn

Email This Entry

Posted by Zack Lynch

I traveled to the University of Pennsylvania yesterday to speak to graduate students and professors associated with the Center for Cognitive Neuroscience. Besides my talk that covered some of the social implications of the rapidly developing neurotechnology industry I had an opportunity to meet with several researchers doing some very interesting research. Here is a quick slice of what these researchers are up to:

Robert Forman: Impact of the Internet on distribution and delivery of legal and illegal drugs via the web. Persuasive research that will surely influence the drug importation debate,

Anjan Chatterjee: The historical analogies between the birth and growth of cosmetic surgery and cosmetic neurology. Very impressive parallels that include the dynamics of market forces.

Amishi Jha: Functional neuroimaging experiments on how neuropharmaceuticals and meditation influence similar aspects of attention in adult ADHD. Persistent meditation can improve focus.

Martha Farah: Director of the Center for Cognitive Neuroscience since 1999. Empirical examination of how a variety of neuropharmaceuticals impact "normal" individuals.

Paul Wolpe: Where to start? Busy bio-neuroethicist who is about to get a lot busier. Writing a book on biotechnical augmentation and ethics. Paul is a very bright individual and this book should be an important contribution. Told me to read the book Better Than Well.

While is was a quick 23 hour trip, it was well worth the time. It was especially nice to meet several students who drove down from Princeton for the talk. For more on the great research occurring at Penn I recommend visiting www.neuroethics.upenn.edu.

Comments (0) + TrackBacks (0) | Category: Neurosociety


POST A COMMENT

Thanks for signing in, . Now you can comment. (sign out)

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)





Remember me?


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
NIO Unveils Top 10 Neuroscience Trends for 2009
NIO CEO Media Tour in NYC Gets Results
O Neurocaster
Manuscript Sent to Japan
2009 Stem Cell Trendsetters in Neurology and Psychiatry
Mental Health Parity Legislation Passes within Financial Package
Holy Neurofinancial Meltdown Bernanke
Interest in Neuropolicy Grows